{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T01:39:07Z","timestamp":1794533947341,"version":"4.9.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,1,11]],"date-time":"2024-01-11T00:00:00Z","timestamp":1704931200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,11]],"date-time":"2024-01-11T00:00:00Z","timestamp":1704931200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"DOI":"10.1007\/s12020-023-03681-4","type":"journal-article","created":{"date-parts":[[2024,1,11]],"date-time":"2024-01-11T11:02:22Z","timestamp":1704970942000},"page":"694-703","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["The combination of doxazosin and metyrosine as a preoperative treatment for pheochromocytomas and paragangliomas"],"prefix":"10.1007","volume":"84","author":[{"given":"Yuka","family":"Ohmachi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7000-8134","authenticated-orcid":false,"given":"Masaaki","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuiko","family":"Inaba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shohei","family":"Makino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin","family":"Urai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Risa","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hironori","family":"Bando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keitaro","family":"Kanie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasutaka","family":"Tsujimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuma","family":"Motomura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuriko","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuka","family":"Oi-Yo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michiko","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genzo","family":"Iguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maki","family":"Kanzawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junya","family":"Furukawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsumi","family":"Shigemura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Mizobuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wataru","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidenori","family":"Fukuoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,11]]},"reference":[{"key":"3681_CR1","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/S0140-6736(05)67139-5","volume":"366","author":"JW Lenders","year":"2005","unstructured":"J.W. Lenders, G. Eisenhofer, M. Mannelli, K. Pacak, Phaeochromocytoma. Lancet 366, 665\u2013675 (2005). https:\/\/doi.org\/10.1016\/S0140-6736(05)67139-5","journal-title":"Lancet"},{"key":"3681_CR2","first-page":"802","volume":"58","author":"CM Beard","year":"1983","unstructured":"C.M. Beard, S.G. Sheps, L.T. Kurland, J.A. Carney, J.T. Lie, Occurrence of pheochromocytoma in Rochester, Minnesota, 1950 through 1979. Mayo Clin. Proc. 58, 802\u2013804 (1983)","journal-title":"Mayo Clin. Proc."},{"key":"3681_CR3","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1530\/ERC-13-0494","volume":"21","author":"N Kimura","year":"2014","unstructured":"N. Kimura, R. Takayanagi, N. Takizawa et al. Pathological grading for predicting metastasis in phaeochromocytoma and paraganglioma. Endocr. Relat. Cancer 21, 405\u2013414 (2014). https:\/\/doi.org\/10.1530\/ERC-13-0494","journal-title":"Endocr. Relat. Cancer"},{"key":"3681_CR4","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s003450050102","volume":"17","author":"MM Walther","year":"1999","unstructured":"M.M. Walther, H.R. Keiser, W.M. Linehan, Pheochromocytoma: evaluation, diagnosis, and treatment. World J. Urol. 17, 35\u201339 (1999). https:\/\/doi.org\/10.1007\/s003450050102","journal-title":"World J. Urol."},{"key":"3681_CR5","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1210\/jc.2014-1498","volume":"99","author":"JW Lenders","year":"2014","unstructured":"J.W. Lenders, Q.Y. Duh, G. Eisenhofer et al. Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 99, 1915\u20131942 (2014). https:\/\/doi.org\/10.1210\/jc.2014-1498","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"3681_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-97964-3","volume":"11","author":"JH Kim","year":"2021","unstructured":"J.H. Kim, H.C. Lee, S.J. Kim et al. Perioperative hemodynamic instability in pheochromocytoma and sympathetic paraganglioma patients. Sci. Rep. 11, 18574 (2021). https:\/\/doi.org\/10.1038\/s41598-021-97964-3","journal-title":"Sci. Rep."},{"key":"3681_CR7","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1053\/j.jvca.2017.02.023","volume":"31","author":"J Naranjo","year":"2017","unstructured":"J. Naranjo, S. Dodd, Y.N. Martin, Perioperative management of pheochromocytoma. J. Cardiothorac. Vasc. Anesth. 31, 1427\u20131439 (2017). https:\/\/doi.org\/10.1053\/j.jvca.2017.02.023","journal-title":"J. Cardiothorac. Vasc. Anesth."},{"key":"3681_CR8","first-page":"360","volume":"44","author":"H Wachtel","year":"2015","unstructured":"H. Wachtel, I. Cerullo, E.K. Bartlett et al. Preoperative metyrosine improves cardiovascular outcomes for patients undergoing surgery for pheochromocytoma and paraganglioma. Pancreas 44, 360 (2015)","journal-title":"Pancreas"},{"key":"3681_CR9","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1053\/jcan.2002.124150","volume":"16","author":"MA Kinney","year":"2002","unstructured":"M.A. Kinney, B.J. Narr, M.A. Warner, Perioperative management of pheochromocytoma. J. Cardiothorac. Vasc. Anesth. 16, 359\u2013369 (2002). https:\/\/doi.org\/10.1053\/jcan.2002.124150","journal-title":"J. Cardiothorac. Vasc. Anesth."},{"key":"3681_CR10","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1161\/01.CIR.14.4.622","volume":"14","author":"WF Kvale","year":"1956","unstructured":"W.F. Kvale, G.M. Roth, W.M. Manger, J.T. Priestley, Pheochromocytoma. Circulation 14, 622\u2013630 (1956). https:\/\/doi.org\/10.1161\/01.CIR.14.4.622","journal-title":"Circulation"},{"key":"3681_CR11","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1111\/j.1365-2044.2005.04156.x","volume":"60","author":"G Lebuffe","year":"2005","unstructured":"G. Lebuffe, D. Dosseh, G. Tek et al. The effect of calcium channel blockers on outcome following the surgical treatment of phaeochromocytomas and paragangliomas. Anesthesia 60, 439\u2013444 (2005). https:\/\/doi.org\/10.1111\/j.1365-2044.2005.04156.x","journal-title":"Anesthesia"},{"key":"3681_CR12","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1530\/EJE-20-1301","volume":"184","author":"K Zawadzka","year":"2021","unstructured":"K. Zawadzka, K. Wi\u0119ckowski, P. Ma\u0142czak et al. Selective vs non-selective alpha-blockade prior to adrenalectomy for pheochromocytoma: systematic review and meta-analysis. Eur. J. Endocrinol. 184, 751\u2013760 (2021). https:\/\/doi.org\/10.1530\/EJE-20-1301","journal-title":"Eur. J. Endocrinol."},{"key":"3681_CR13","unstructured":"S. Yoon, S.L. Gianturco, L.L. Pavlech, K.D. Storm, M.V. Yuen, A.N. Mattingly, Phenoxybenzamine hydrochloride: Summary report. University of Maryland Center of Excellence in Regulatory Science and Innovation (M-CERSI). https:\/\/archive.hshsl.umaryland.edu\/handle\/10713\/15464 (2020). Accessed 12 Dec 2023"},{"key":"3681_CR14","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1007\/s00268-002-6667-z","volume":"26","author":"C Prys-Roberts","year":"2002","unstructured":"C. Prys-Roberts, J.R. Farndon, Efficacy and safety of doxazosin for perioperative management of patients with pheochromocytoma. World J. Surg. 26, 1037\u20131042 (2002). https:\/\/doi.org\/10.1007\/s00268-002-6667-z","journal-title":"World J. Surg."},{"key":"3681_CR15","doi-asserted-by":"publisher","first-page":"2429","DOI":"10.1097\/HJH.0b013e32834d24d9","volume":"29","author":"Y Shao","year":"2011","unstructured":"Y. Shao, R. Chen, Z.J. Shen et al. Preoperative alpha blockade for normotensive pheochromocytoma: is it necessary? J. Hypertens. 29, 2429\u20132432 (2011). https:\/\/doi.org\/10.1097\/HJH.0b013e32834d24d9","journal-title":"J. Hypertens."},{"key":"3681_CR16","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1530\/ERC-21-0230","volume":"28","author":"M Araujo-Castro","year":"2021","unstructured":"M. Araujo-Castro, R. Garcia Centeno, M.C. L\u00f3pez-Garc\u00eda et al. Risk factors for intraoperative complications in pheochromocytomas. Endocr. Relat. Cancer 28, 695\u2013703 (2021). https:\/\/doi.org\/10.1530\/ERC-21-0230","journal-title":"Endocr. Relat. Cancer"},{"key":"3681_CR17","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1308\/rcsann.2021.0133","volume":"104","author":"HK Van Den","year":"2022","unstructured":"H.K. Van Den, A. Paspala, N. Chander et al. To block, or not to block \u2026 is it still the question? Effectiveness of alpha- and beta-blockade in phaeochromocytoma surgery: an institutional analysis. Ann. R. Coll. Surg. Engl. 104, 138\u2013143 (2022). https:\/\/doi.org\/10.1308\/rcsann.2021.0133","journal-title":"Ann. R. Coll. Surg. Engl."},{"key":"3681_CR18","doi-asserted-by":"publisher","first-page":"e2393","DOI":"10.1210\/clinem\/dgab130","volume":"106","author":"LM Gruber","year":"2021","unstructured":"L.M. Gruber, S. Jasim, A. Ducharme-Smith, T. Weingarten, W.F. Young Jr., I. Bancos, The role for metyrosine in the treatment of patients with pheochromocytoma and paraganglioma. J. Clin. Endocrinol. Metab. 106, e2393\u2013e2401 (2021). https:\/\/doi.org\/10.1210\/clinem\/dgab130","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"3681_CR19","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1097\/00000658-199011000-00010","volume":"212","author":"RR Perry","year":"1990","unstructured":"R.R. Perry, H.R. Keiser, J.A. Norton et al. Surgical management of pheochromocytoma with the use of metyrosine. Ann. Surg. 212, 621\u2013628 (1990). https:\/\/doi.org\/10.1097\/00000658-199011000-00010","journal-title":"Ann. Surg."},{"key":"3681_CR20","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1001\/archinte.1997.00440290087009","volume":"157","author":"J Steinsapir","year":"1997","unstructured":"J. Steinsapir, A.A. Carr, L.M. Prisant, E.D. Bransome Jr., Metyrosine and pheochromocytoma. Arch. Intern. Med. 157, 901\u2013906 (1997). https:\/\/doi.org\/10.1001\/archinte.1997.00440290087009","journal-title":"Arch. Intern. Med."},{"key":"3681_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1507\/endocrine.94.S.August_1","volume":"94","author":"The Japan Endocrine Society","year":"2018","unstructured":"The Japan Endocrine Society, Clinical practice guideline of pheochromocytoma paraganglioma] (in Japanese). Jpn. J. Endocrinol. 94, 1\u201390 (2018). https:\/\/doi.org\/10.1507\/endocrine.94.S.August_1","journal-title":"Jpn. J. Endocrinol."},{"key":"3681_CR22","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1016\/j.urology.2007.09.042","volume":"70","author":"K Tanaka","year":"2007","unstructured":"K. Tanaka, I. Hara, K. Yamaguchi, M. Takeda, A. Takenaka, M. Fujisawa, Laparoscopic resection of a lower posterior mediastinal tumor: feasibility of using a transdiaphragmatic approach. Urology 70, 1215\u20131218 (2007). https:\/\/doi.org\/10.1016\/j.urology.2007.09.042","journal-title":"Urology"},{"key":"3681_CR23","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1016\/S0140-6736(65)90062-0","volume":"2","author":"A Sjoerdsma","year":"1965","unstructured":"A. Sjoerdsma, K. Engelman, S. Spector, S. Udenfriend, Inhibition of catecholamine synthesis in man with alpha-methyl-tyrosine, an inhibitor of tyrosine hydroxylase. Lancet 2, 1092\u20131094 (1965). https:\/\/doi.org\/10.1016\/S0140-6736(65)90062-0","journal-title":"Lancet"},{"key":"3681_CR24","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1507\/endocrj.EJ17-0276","volume":"65","author":"M Naruse","year":"2018","unstructured":"M. Naruse, F. Satoh, A. Tanabe et al. Efficacy and safety of metyrosine in pheochromocytoma\/paraganglioma: a multi-center trial in Japan. Endocr. J. 65, 359\u2013371 (2018). https:\/\/doi.org\/10.1507\/endocrj.EJ17-0276","journal-title":"Endocr. J."},{"key":"3681_CR25","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.urology.2016.10.012","volume":"100","author":"TN Weingarten","year":"2017","unstructured":"T.N. Weingarten, T.L. Welch, T.L. Moore et al. Preoperative levels of catecholamines and metanephrines and intraoperative hemodynamics of patients undergoing pheochromocytoma and paraganglioma resection. Urology 100, 131\u2013138 (2017). https:\/\/doi.org\/10.1016\/j.urology.2016.10.012","journal-title":"Urology"},{"key":"3681_CR26","doi-asserted-by":"publisher","first-page":"S646","DOI":"10.1245\/s10434-015-4862-z","volume":"22","author":"H Wachtel","year":"2015","unstructured":"H. Wachtel, E.H. Kennedy, S. Zaheer et al. Preoperative metyrosine improves cardiovascular outcomes for patients undergoing surgery for pheochromocytoma and paraganglioma. Ann. Surg. Oncol. 22, S646\u2013S654 (2015). https:\/\/doi.org\/10.1245\/s10434-015-4862-z","journal-title":"Ann. Surg. Oncol."},{"key":"3681_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijsu.2017.08.026","volume":"46","author":"JJ Butz","year":"2017","unstructured":"J.J. Butz, T.N. Weingarten, A.N. Cavalcante et al. Perioperative hemodynamics and outcomes of patients on metyrosine undergoing resection of pheochromocytoma or paraganglioma. Int. J. Surg. 46, 1\u20136 (2017). https:\/\/doi.org\/10.1016\/j.ijsu.2017.08.026","journal-title":"Int. J. Surg."},{"key":"3681_CR28","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1001\/archinte.163.3.361","volume":"163","author":"H Arima","year":"2003","unstructured":"H. Arima, Y. Tanizaki, Y. Kiyohara et al. Validity of the JNC VI recommendations for the management of hypertension in a general population of Japanese elderly: the Hisayama study. Arch. Intern. Med. 163, 361\u2013366 (2003). https:\/\/doi.org\/10.1001\/archinte.163.3.361","journal-title":"Arch. Intern. Med."},{"key":"3681_CR29","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.1016\/j.injury.2017.06.023","volume":"48","author":"N Sheffy","year":"2017","unstructured":"N. Sheffy, I. Bentov, B. Mills, B.G. Nair, G.A. Rooke, M.S. Vavilala, Perioperative hypotension and discharge outcomes in non-critically injured trauma patients, a single centre retrospective cohort study. Injury 48, 1956\u20131963 (2017). https:\/\/doi.org\/10.1016\/j.injury.2017.06.023","journal-title":"Injury"},{"key":"3681_CR30","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1053\/j.jvca.2004.11.034","volume":"19","author":"ML Ogletree","year":"2005","unstructured":"M.L. Ogletree, J. Sprung, C.S. Moravec, Effects of remifentanil on the contractility of failing human heart muscle. J. Cardiothorac. Vasc. Anesth. 19, 763\u2013767 (2005). https:\/\/doi.org\/10.1053\/j.jvca.2004.11.034","journal-title":"J. Cardiothorac. Vasc. Anesth."},{"key":"3681_CR31","doi-asserted-by":"publisher","first-page":"81","DOI":"10.2165\/00003495-198121020-00001","volume":"21","author":"RN Brogden","year":"1981","unstructured":"R.N. Brogden, R.C. Heel, T.M. Speight, G.S. Avery, \u03b1-Methyl-p-tyrosine: a review of its pharmacology and clinical use. Drugs 21, 81\u201389 (1981). https:\/\/doi.org\/10.2165\/00003495-198121020-00001","journal-title":"Drugs"}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-023-03681-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-023-03681-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-023-03681-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,7]],"date-time":"2024-05-07T02:23:29Z","timestamp":1715048609000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-023-03681-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,11]]},"references-count":31,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,5]]}},"alternative-id":["3681"],"URL":"https:\/\/doi.org\/10.1007\/s12020-023-03681-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3413233\/v1","asserted-by":"object"}]},"ISSN":["1559-0100"],"issn-type":[{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,11]]},"assertion":[{"value":"5 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This retrospective observational study was approved by the Institutional Review Board of the Kobe University Hospital (#B220221) and performed in accordance with the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from the participants using an opt-out approach.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}]}}